{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:22:19Z","timestamp":1790778139243,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA136578"],"award-info":[{"award-number":["R01CA136578"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA141298"],"award-info":[{"award-number":["R01CA141298"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA09001"],"award-info":[{"award-number":["T32CA09001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25CA112355"],"award-info":[{"award-number":["R25CA112355"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA090381"],"award-info":[{"award-number":["P50CA090381"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["PF-14-140-01-CCE"],"award-info":[{"award-number":["PF-14-140-01-CCE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["U01CA167552"],"award-info":[{"award-number":["U01CA167552"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tissue Microarray Core Facility at the Dana-Farber\/Harvard Cancer Center","award":["P30CA06516"],"award-info":[{"award-number":["P30CA06516"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,31]]},"DOI":"10.1093\/carcin\/bgy112","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T19:18:31Z","timestamp":1534965511000},"page":"1431-1437","source":"Crossref","is-referenced-by-count":51,"title":["Expression of IGF\/insulin receptor in prostate cancer tissue and progression to lethal disease"],"prefix":"10.1093","volume":"39","author":[{"given":"Thomas U","family":"Ahearn","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Peisch","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pettersson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ericka M","family":"Ebot","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy Ke","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E","family":"Graff","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A","family":"Sinnott","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Fazli","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Center, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L","family":"Judson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek A","family":"Bismar","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R","family":"Rider","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA, USA"},{"name":"Boston University School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Gerke","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June M","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Flavin","sequence":"additional","affiliation":[{"name":"Department of Histopathology Research, Trinity College, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D","family":"Sesso","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Divisions of Preventive Medicine and Aging, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Finn","sequence":"additional","affiliation":[{"name":"Department of Histopathology Research, Trinity College, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L","family":"Giovannucci","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA, USA"},{"name":"Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gleave","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Center, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Loda","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Genetics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pollak","sequence":"additional","affiliation":[{"name":"Cancer Prevention Research Unit, Departments of Medicine and Oncology, Lady Davis Research Institute of the Jewish General Hospital and McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei A","family":"Mucci","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Transdisciplinary Prostate Cancer Partnership (ToPCaP)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"key\n\t\t\t\t2019010210585242100_CIT0001","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0002","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0003","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S1470-2045(08)70235-3","article-title":"Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis","volume":"9","author":"Ma","year":"2008","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1940-6207.CAPR-09-0188","article-title":"Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"3","author":"Neuhouser","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0005","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ijc.25381","article-title":"Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993\u20132004","volume":"128","author":"Nimptsch","year":"2011","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0006","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1055-9965.EPI-12-0481-T","article-title":"Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition","volume":"21","author":"Price","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pros.20852","article-title":"Insulin receptor expression by human prostate cancers","volume":"69","author":"Cox","year":"2009","journal-title":"Prostate"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0008","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1158\/1535-7163.MCT-12-0648","article-title":"Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts","volume":"12","author":"Fahrenholtz","year":"2013","journal-title":"Mol. Cancer Ther"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0009","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1158\/1535-7163.MCT-13-0842","article-title":"The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer","volume":"13","author":"Ibuki","year":"2014","journal-title":"Mol. Cancer Ther"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2009.04.036","article-title":"ETS gene fusions in prostate cancer: from discovery to daily clinical practice","volume":"56","author":"Tomlins","year":"2009","journal-title":"Eur. Urol"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0011","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Abeshouse","year":"2015","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0012","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/djt332","article-title":"Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG","volume":"105","author":"Pettersson","year":"2013","journal-title":"J. Natl Cancer Inst"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0013","doi-asserted-by":"crossref","first-page":"51375","DOI":"10.18632\/oncotarget.9837","article-title":"TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1","volume":"7","author":"Meisel Sharon","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0014","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12885-017-3356-8","article-title":"Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status","volume":"17","author":"Mancarella","year":"2017","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2008.862","article-title":"Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians\u2019 Health Study II randomized controlled trial","volume":"301","author":"Gaziano","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0091-7435(85)90031-3","article-title":"A randomized trial of aspirin and beta-carotene among U.S. physicians","volume":"14","author":"Hennekens","year":"1985","journal-title":"Prev. Med"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0017","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/ijc.22788","article-title":"Risk factors for prostate cancer incidence and progression in the health professionals follow-up study","volume":"121","author":"Giovannucci","year":"2007","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0018","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2008.20.4669","article-title":"Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3","volume":"27","author":"Stark","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0019","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1200\/JCO.2008.20.8876","article-title":"Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study","volume":"27","author":"Mucci","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0020","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/1055-9965.EPI-13-0349","article-title":"Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study","volume":"22","author":"Zu","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0021","article-title":"A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer","volume":"108","author":"Ahearn","year":"2016","journal-title":"J. Natl Cancer Inst"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0022","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/1055-9965.EPI-12-0042","article-title":"The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis","volume":"21","author":"Pettersson","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0023","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.coph.2008.07.004","article-title":"Targeting insulin and insulin-like growth factor signalling in oncology","volume":"8","author":"Pollak","year":"2008","journal-title":"Curr. Opin. Pharmacol"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0024","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-149-7-200810070-00006","article-title":"Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies","volume":"149","author":"Roddam","year":"2008","journal-title":"Ann. Intern. Med"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0025","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/ijc.24202","article-title":"Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis","volume":"124","author":"Rowlands","year":"2009","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0026","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1158\/0008-5472.CAN-15-1551","article-title":"A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk","volume":"76","author":"Travis","year":"2016","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0027","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/ijc.29295","article-title":"Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer","volume":"136","author":"Cao","year":"2015","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0028","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10552-011-9883-8","article-title":"Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer","volume":"23","author":"Rowlands","year":"2012","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0029","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1055-9965.EPI-06-1062","article-title":"Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition","volume":"16","author":"Allen","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/jnci\/94.14.1099","article-title":"Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer","volume":"94","author":"Chan","year":"2002","journal-title":"J. Natl Cancer Inst"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0031","doi-asserted-by":"crossref","first-page":"dju085","DOI":"10.1093\/jnci\/dju218","article-title":"Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival","volume":"106","author":"Cao","year":"2014","journal-title":"J. Natl Cancer Inst"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0032","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/ERC-12-0250","article-title":"IGF2 increases de novo steroidogenesis in prostate cancer cells","volume":"20","author":"Lubik","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0033","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.18632\/oncotarget.1884","article-title":"Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis","volume":"5","author":"Heidegger","year":"2014","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0034","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1210\/en.2012-1348","article-title":"Diverse functions of IGF\/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells","volume":"153","author":"Heidegger","year":"2012","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0035","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1210\/me.2015-1073","article-title":"Both IGF1R and INSR knockdown exert antitumorigenic effects in prostate cancer in vitro and in vivo","volume":"29","author":"Ofer","year":"2015","journal-title":"Mol. Endocrinol"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0036","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10552-014-0369-3","article-title":"Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study","volume":"25","author":"Lai","year":"2014","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0037","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1158\/1940-6207.CAPR-10-0053","article-title":"Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study","volume":"3","author":"Lai","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0038","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/ijc.22587","article-title":"Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden","volume":"120","author":"Stocks","year":"2007","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0039","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr. Rev"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jcb.20929","article-title":"Interaction of IGF signaling and the androgen receptor in prostate cancer progression","volume":"99","author":"Wu","year":"2006","journal-title":"J. Cell Biochem"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0041","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jcp.22784","article-title":"Insulin-like growth factor 1 stimulation of androgen receptor activity requires \u03b2(1A) integrins","volume":"227","author":"Sayeed","year":"2012","journal-title":"J. Cell. Physiol"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0042","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.18632\/oncotarget.3425","article-title":"ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents","volume":"6","author":"Mancarella","year":"2015","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0043","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1158\/0008-5472.CAN-07-3074","article-title":"A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study","volume":"68","author":"Martins","year":"2008","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0044","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/path.2499","article-title":"The insulin-like growth factor system and sarcomas","volume":"217","author":"Rikhof","year":"2009","journal-title":"J. Pathol"},{"key":"key\n\t\t\t\t2019010210585242100_CIT0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pros.21265","article-title":"TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients","volume":"71","author":"Magi-Galluzzi","year":"2011","journal-title":"Prostate"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/39\/12\/1431\/27365925\/bgy112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T03:49:42Z","timestamp":1604807382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/39\/12\/1431\/5079148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,8,24]]},"published-print":{"date-parts":[[2018,12,31]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgy112","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,8,24]]}}}